ClinicalTrials.govpublic full text
p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer
esophageal cancer, predictive marker, personalized therapy, response assessment, p53 genotype, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 903135
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.